Description
| Specialty | ARAVEN IC |
|---|---|
| Dosage | 10 mg, 300 mg |
| Form | Film-coated tablet |
| Presentation | B/30 |
| Primary Packaging | Blister |
| Specification | Alu/Alu, white opaque PVC/PVDC/Alu |
| INN | AMLODIPINE, IRBESARTAN |
| VEIC Classification | Essential |
| Therapeutic Class | CARDIOVASCULAR SYSTEM |
| Subclass | AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| Laboratory | PHILADELPHIA PHARMA |
| Table | A |
| Shelf Life | 24 (months) |
| Generic/Brand | Generic |
| Marketing Authorization | 9353233 |
| Authorization Date | 2019-02-23 |
| Range | Cardio-Metabolic Range |
Reviews
There are no reviews yet.